SANA
Sana Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.30
+1.32%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$2.32
From 52W high−59.72%
Volume2.60M
Market cap$688.53M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$2.32
From 52W high
−59.72%
Volume
2.60M
Market cap
$688.53M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−3.0x
P/E (TTM)
—
RSI (14)
27.9
MomentumView details →
1D Return
+1.32%
YTD Return
−44.10%
SummaryUpdated Jun 1, 2026
Sana Biotechnology, Inc. (NASDAQ:SANA) is a biotechnology company founded in 2018 and headquartered in Seattle, Washington. Originally incorporated as FD Therapeutics, Inc., the company changed its name to Sana Biotechnology in September 2018 before going public in February 2021. Sana focuses on developing engineered cells as medicines, representing a cutting-edge approach in biotechnology where living cells are modified to treat diseases rather than using traditional small molecule drugs or biologics.
Similar companies
Latest newsMore news →